← Eichor
Condition: Tetanus Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tetanus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTp
Phase 3 · 10 location(s) · GlaxoSmithKline · NCT07596173Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children
Phase 2 · 1 location(s) · International Vaccine Institute · NCT07509047A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTp
Phase 3 · 18 location(s) · GlaxoSmithKline · NCT07596199A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following In
Phase N/A · 1 location(s) · Zhuhai Trinomab Pharmaceutical Co., Ltd. · NCT07347938Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
Phase 1 · 3 location(s) · Institute of Medical Biology, Chinese Academy of Medical Sci · NCT06184542Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial
NA · 4 location(s) · Universiti Putra Malaysia · NCT06815250Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants
NA · 1 location(s) · Jiangsu Province Centers for Disease Control and Prevention · NCT06605755A Registry： Siltartoxatug Injection for Tetanus Prophylaxis Following Injury
Phase N/A · 4 location(s) · Zhuhai Trinomab Pharmaceutical Co., Ltd. · NCT07107932Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants
Phase 3 · 1 location(s) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · NCT06344065A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults
Phase 1/Phase 2 · 1 location(s) · GC Biopharma Corp · NCT06997627A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR20
Phase 3 · 20 location(s) · Genrix (Shanghai) Biopharmaceutical Co., Ltd. · NCT06635798A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalen
Phase 2/Phase 3 · 1 location(s) · LG Chem · NCT06947499Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135
Phase 1 · 1 location(s) · CanSino Biologics Inc. · NCT07203755Tetanus Severity Score for Prediction of Mortality in Manifest Tetanus
Phase N/A · 1 location(s) · Ain Shams University · NCT07512167Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy
Phase 4 · 4 location(s) · Canadian Immunization Research Network · NCT07097012Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy
Phase 4 · 1 location(s) · Women and Infants Hospital of Rhode Island · NCT06135636Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial
Phase 3 · 1 location(s) · Changchun BCHT Biotechnology Co. · NCT07112144
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.